# AMC Robotics Corp: financial statements, quarterly

AMCI · Nasdaq · CIK 1937891 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/amci.md) · [Financials](/companies/amci/financials.md) · [Filings](/companies/amci/filings.md) · [Insiders](/companies/amci/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/amci/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | [1.8](/filings/0001493152-26-024300.md) | [1.4](/filings/0001493152-26-038443.md) | not reported | not reported | [1.2](/filings/0001493152-26-024300.md) | [0.9](/filings/0001493152-26-038443.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | [1.3](/filings/0001493152-26-024300.md) | [1.1](/filings/0001493152-26-038443.md) | not reported | not reported | [0.2](/filings/0001493152-26-024300.md) | [0.2](/filings/0001493152-26-038443.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.5](/filings/0001493152-26-024300.md) | [0.3](/filings/0001493152-26-038443.md) | not reported | not reported | [1.0](/filings/0001493152-26-024300.md) | [0.8](/filings/0001493152-26-038443.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001493152-26-024300.md) | [0.0](/filings/0001493152-26-038443.md) | not reported | not reported | [0.0](/filings/0001493152-26-024300.md) | [0.0](/filings/0001493152-26-038443.md) |
| Operating income | $m | [(0.2)](/filings/0001493152-24-046848.md) | [(0.2) d](/filings/0001641172-25-004572.md) | [(0.2)](/filings/0001641172-25-011546.md) | [(0.1)](/filings/0001641172-25-024039.md) | [(0.2)](/filings/0001493152-25-024315.md) | [(2.0) d](/filings/0001493152-26-018144.md) | [(0.7)](/filings/0001493152-26-024300.md) | [(0.7)](/filings/0001493152-26-038443.md) | [(2.8)](/filings/0001493152-25-024315.md) | [2.7 d](/filings/0001493152-26-018144.md) | [0.1](/filings/0001493152-26-024300.md) | [(0.2)](/filings/0001493152-26-038443.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001493152-26-024300.md) | [0.0](/filings/0001493152-26-038443.md) | not reported | not reported | not reported | not reported |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001493152-26-024300.md) | [0.0](/filings/0001493152-26-038443.md) | not reported | not reported | [0.0](/filings/0001493152-26-024300.md) | [(0.0)](/filings/0001493152-26-038443.md) |
| Net income | $m | [0.8](/filings/0001493152-24-046848.md) | [0.8 d](/filings/0001641172-25-004572.md) | [0.3](/filings/0001493152-25-024315.md) | [0.4](/filings/0001493152-25-024315.md) | [0.5](/filings/0001493152-25-024315.md) | [(2.0) d](/filings/0001493152-26-018144.md) | [(0.1)](/filings/0001493152-26-038443.md) | [(0.2)](/filings/0001493152-26-038443.md) | [(2.7)](/filings/0001493152-25-024315.md) | [(22.2) d](/filings/0001493152-26-018144.md) | [0.1](/filings/0001493152-26-038443.md) | [(0.2)](/filings/0001493152-26-038443.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | [0.00](/filings/0001493152-26-024300.md) | [(0.01)](/filings/0001493152-26-038443.md) | not reported | not reported | [0.01](/filings/0001493152-26-024300.md) | [(0.01)](/filings/0001493152-26-038443.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | not reported | not reported | [0.00](/filings/0001493152-26-024300.md) | [(0.01)](/filings/0001493152-26-038443.md) | not reported | not reported | [0.01](/filings/0001493152-26-024300.md) | [(0.01)](/filings/0001493152-26-038443.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.1](/filings/0001493152-23-039320.md) | [0.0](/filings/0001641172-25-004572.md) | [0.0](/filings/0001493152-24-020758.md) | [0.0](/filings/0001493152-24-033092.md) | [0.0](/filings/0001493152-24-046848.md) | [0.4](/filings/0001493152-26-018144.md) | [0.0](/filings/0001641172-25-011546.md) | [0.0](/filings/0001641172-25-024039.md) | [0.0](/filings/0001493152-25-024315.md) | [7.0](/filings/0001493152-26-038443.md) | [6.6](/filings/0001493152-26-024300.md) | [4.5](/filings/0001493152-26-038443.md) |
| Current assets | $m | [0.1](/filings/0001493152-23-039320.md) | [0.1](/filings/0001641172-25-004572.md) | [0.1](/filings/0001493152-24-020758.md) | [0.1](/filings/0001493152-24-033092.md) | [0.0](/filings/0001493152-24-046848.md) | [7.2](/filings/0001493152-26-018144.md) | [0.1](/filings/0001641172-25-011546.md) | [0.0](/filings/0001641172-25-024039.md) | [0.0](/filings/0001493152-25-024315.md) | [11.1](/filings/0001493152-26-038443.md) | [11.2](/filings/0001493152-26-024300.md) | [10.1](/filings/0001493152-26-038443.md) |
| Total assets | $m | [73.1](/filings/0001493152-23-039320.md) | [50.9](/filings/0001641172-25-004572.md) | [51.6](/filings/0001493152-24-020758.md) | [52.2](/filings/0001493152-24-033092.md) | [53.1](/filings/0001493152-24-046848.md) | [7.3](/filings/0001493152-26-018144.md) | [18.5](/filings/0001641172-25-011546.md) | [18.8](/filings/0001641172-25-024039.md) | [19.0](/filings/0001493152-25-024315.md) | [11.2](/filings/0001493152-26-038443.md) | [11.3](/filings/0001493152-26-024300.md) | [11.2](/filings/0001493152-26-038443.md) |
| Current liabilities | $m | [0.1](/filings/0001493152-23-039320.md) | [0.4](/filings/0001641172-25-004572.md) | [0.7](/filings/0001493152-24-020758.md) | [0.9](/filings/0001493152-24-033092.md) | [1.3](/filings/0001493152-24-046848.md) | [9.7](/filings/0001493152-26-018144.md) | [2.2](/filings/0001641172-25-011546.md) | [2.5](/filings/0001641172-25-024039.md) | [5.3](/filings/0001493152-25-024315.md) | [0.8](/filings/0001493152-26-038443.md) | [0.8](/filings/0001493152-26-024300.md) | [0.9](/filings/0001493152-26-038443.md) |
| Total liabilities | $m | not reported | [0.4](/filings/0001641172-25-004572.md) | [0.7](/filings/0001493152-24-020758.md) | [0.9](/filings/0001493152-24-033092.md) | [1.3](/filings/0001493152-24-046848.md) | [9.7](/filings/0001493152-26-018144.md) | [2.2](/filings/0001641172-25-011546.md) | [2.5](/filings/0001641172-25-024039.md) | [5.3](/filings/0001493152-25-024315.md) | [0.9](/filings/0001493152-26-038443.md) | [0.8](/filings/0001493152-26-024300.md) | [0.9](/filings/0001493152-26-038443.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [0.8](/filings/0001493152-26-018144.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [0.0](/filings/0001493152-24-046848.md) | [(1.6)](/filings/0001493152-26-018144.md) | [(0.6)](/filings/0001493152-25-024315.md) | [(0.9)](/filings/0001493152-25-024315.md) | [(1.3)](/filings/0001493152-25-024315.md) | [(2.3)](/filings/0001493152-26-038443.md) | [(2.4)](/filings/0001493152-26-038443.md) | [2.4](/filings/0001493152-26-038443.md) | [(5.2)](/filings/0001493152-25-024315.md) | [10.3](/filings/0001493152-26-038443.md) | [10.5](/filings/0001493152-26-038443.md) | [10.3](/filings/0001493152-26-038443.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(163) d](/filings/0001493152-24-046848.md) | [(29.3) d](/filings/0001641172-25-004572.md) | [(14.8)](/filings/0001641172-25-011546.md) | [0.0 d](/filings/0001641172-25-024039.md) | [(6.7) d](/filings/0001493152-25-024315.md) | [590 d](/filings/0001493152-26-018144.md) | [204](/filings/0001493152-26-024300.md) | [471 d](/filings/0001493152-26-038443.md) | [(676) d](/filings/0001493152-25-024315.md) | [(5,555) d](/filings/0001493152-26-018144.md) | [(392)](/filings/0001493152-26-024300.md) | [(1,088) d](/filings/0001493152-26-038443.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [18.0](/filings/0001493152-26-024300.md) | [18.0](/filings/0001493152-26-038443.md) | [24.8](/filings/0001493152-26-024300.md) | [22.6](/filings/0001493152-26-038443.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 22,600,363 at 2026-08-11, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038443.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.